IRIX | tickerfilter.com

Fundamental analysis

22%

Profitability 25%

Dept financing 14%

Liquidity 43%

Performance 15%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

6.10%

1 Month

-1.69%

3 Months

-3.87%

6 Months

-18.69%

1 Year

-32.95%

2 Year

-13.86%

Key data

Stock price

$1.74

P/E Ratio

0.00

DAY RANGE

$1.66 - $1.90

EPS

$0.00

52 WEEK RANGE

$1.40 - $3.65

52 WEEK CHANGE

-$33.08

MARKET CAP

33.184 M

YIELD

N/A

SHARES OUTSTANDING

16.509 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/12/2024

BETA

0.60

PUBLIC FLOAT

AVERAGE 10 VOLUME

$51,611

AVERAGE 30 VOLUME

$31,309

Company detail

CEO: David I. Bruce
Region: US
Website: iridex.com
Employees: 120
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name in 1995.

IRIX - IRIDEX CORP